JA

Juber Alom Barbhuiya

Active Director Director DIN 09558539
DIN 09558539 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Juber Alom Barbhuiya

Data last updated:

Juber Alom Barbhuiya is a Director at Repolo Pharma Private Limited (since 2022). The company operates in Chemicals.

DIN 09558539
Primary Designation Director
Industry Chemicals
First Appointment 01 Apr 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Repolo Pharma Private Limited U24239AS2022PTC022774
Director01 Apr 20222022Active

Board colleagues of Juber Alom Barbhuiya

Directorship timeline

Open interactive timeline →
Repolo Pharma Private Limited
Premium access

Shareholding and investment profile for Juber Alom Barbhuiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Juber Alom Barbhuiya

Juber Alom Barbhuiya currently holds 1 directorship: Repolo Pharma Private Limited (Director, since 01 Apr 2022).

Juber Alom Barbhuiya was first appointed on 01 Apr 2022 as Director at Repolo Pharma Private Limited.

The current boards of Juber Alom Barbhuiya's companies include Jimima Aktar (Repolo Pharma Private Limited), Kazi Kamruzzaman (Repolo Pharma Private Limited), Kritartha Sarma (Repolo Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available